Merck to Participate in the TD Cowen 45th Annual Health Care Conference
Li, executive vice president and president, Merck Research Laboratories, are scheduled to participate in a fireside chat at ...
BioSpace5d
The Search for the Next Keytruda: Immuno-Oncology’s Next Play
More than a decade after Merck’s Keytruda and BMS’ Yervoy ushered in the immuno-oncology revolution, the space is at a ...
Medscape6d
Drug Labels Often Neglect to Inform About Obesity Dosing
Obesity and pharmacology experts are warning about hidden safety risks and efficacy issues for many types of medications in ...
Hosted on MSN25d
Merck stock price target cut to $115 at Guggenheim
O n Wednesday, Guggenheim maintained a Buy rating on Merck (NYSE:MRK) shares but reduced the price target to $115 from $122. The adjustment follows a comprehensive review of the pharmaceutical ...
Le Lézard13d
IFS appoints Matt Breslin as President, North America
IFS, the leading provider of enterprise cloud and Industrial AI software, has welcomed Matt Breslin as the newly appointed President, North America. Breslin joins from Upland Software, a global ...
pharmaphorum2d
Pharma holds it breath for ’25 as the sun shines on JP Morgan conference
Domain’s Sean MacDonald noted that many big pharma companies are looking to replenish their pipelines as big-selling drugs, such as Merck & Co ... of concept].” Carolyn Porter, CEO of ...
The Daily News13d
Merck to Participate in the TD Cowen 45th Annual Health Care Conference
Merck (NYSE: MRK), known as MSD outside of the United States and Canada, announced today that Caroline Litchfield, executive vice president and chief financial officer, and Dr. Dean Y. Li, executive ...